$BFRI
Biofrontera Inc. Stock $bfri

$bfri Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224045220 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$9.012M
YoY Change		1.3%
Cost Of Revenue		$4.877M
YoY Change		6.25%
Gross Profit		$4.135M
YoY Change		-4.06%
Gross Profit Margin		45.88%
Selling, General & Admin		$8.426M
YoY Change		-2.24%
% of Gross Profit		203.77%
Research & Development		$669.0K
YoY Change		1927.27%
% of Gross Profit		16.18%
Depreciation & Amortization		$129.0K
YoY Change		-0.77%
% of Gross Profit		3.12%
Operating Expenses		$13.97M
YoY Change		3.37%
Operating Profit		-$4.960M
YoY Change		7.36%
Interest Expense		$8.000K
YoY Change		-94.37%
% of Operating Profit
Other Income/Expense, Net		-$706.0K
YoY Change		-58.98%
Pretax Income		-$5.666M
YoY Change		-10.65%
Income Tax		$3.000K
% Of Pretax Income
Net Earnings		-$5.669M
YoY Change		-10.61%
Net Earnings / Revenue		-62.91%
Basic Earnings Per Share		-$0.98
Diluted Earnings Per Share		-$0.98
COMMON SHARES
Basic Shares Outstanding	7.749M shares	5.544M shares
Diluted Shares Outstanding		5.774M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$2.881M
YoY Change		-57.38%
Cash & Equivalents		$2.873M
Short-Term Investments		$8.000K
Other Short-Term Assets		$2.650M
YoY Change		881.48%
Inventory		$6.526M
Prepaid Expenses
Receivables		$4.874M
Other Receivables		$0.00
Total Short-Term Assets		$16.93M
YoY Change		-42.82%
LONG-TERM ASSETS
Property, Plant & Equipment		$82.00K
YoY Change		-46.75%
Goodwill
YoY Change
Intangibles		$39.00K
YoY Change		-98.57%
Long-Term Investments
YoY Change
Other Assets		$383.0K
YoY Change		-21.84%
Total Long-Term Assets		$1.585M
YoY Change		-64.72%
TOTAL ASSETS
Total Short-Term Assets		$16.93M
Total Long-Term Assets		$1.585M
Total Assets		$18.52M
YoY Change		-45.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$5.707M
YoY Change		-33.79%
Accrued Expenses		$4.655M
YoY Change		-57.83%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$11.03M
YoY Change		-62.12%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$29.00K
YoY Change		-23.68%
Total Long-Term Liabilities		$29.00K
YoY Change		-23.68%
TOTAL LIABILITIES
Total Short-Term Liabilities		$11.03M
Total Long-Term Liabilities		$29.00K
Total Liabilities		$12.99M
YoY Change		-60.73%
SHAREHOLDERS EQUITY
Retained Earnings		-$116.0M
YoY Change		12.4%
Common Stock		$7.000K
YoY Change		600.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$5.530M
YoY Change
Total Liabilities & Shareholders Equity		$18.52M
YoY Change		-45.71%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$5.669M
YoY Change		-10.61%
Depreciation, Depletion And Amortization		$129.0K
YoY Change		-0.77%
Cash From Operating Activities		-$1.208M
YoY Change		-39.6%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities		$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-298.0K
YoY Change		-150.51%
NET CHANGE
Cash From Operating Activities		-1.208M
Cash From Investing Activities		0.000
Cash From Financing Activities		-298.0K
Net Change In Cash		-1.506M
YoY Change		47.65%
FREE CASH FLOW
Cash From Operating Activities		-$1.208M
Capital Expenditures		$0.00
Free Cash Flow		-$1.208M
YoY Change		-39.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001858685
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1343000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	5162000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	23075000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	134000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	482000	usd
CY2023Q4	us-gaap	Assets Assets	27932000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	82000	usd
CY2024Q3	us-gaap	Assets Assets	18516000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5773993	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1366842	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1366842	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4833091	shares
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent		usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	BFRI	Revenues Related Party RevenuesRelatedParty		usd
CY2024Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1		usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1		usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	BFRI	Stock Issued During Period Value Exercise Of Prefunded Warrants StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023Q3	BFRI	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	BFRI	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
	BFRI	Proceeds From Exercise Of Warrants ProceedsFromExerciseOfWarrants		usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
	BFRI	Interest Paid Related Party InterestPaidRelatedParty		usd
	BFRI	Conversion Of Warrant Liability To Equity ConversionOfWarrantLiabilityToEquity		usd
CY2023Q4	BFRI	Assets Held For Sale Not Part Of Disposal Group Gross Current AssetsHeldForSaleNotPartOfDisposalGroupGrossCurrent		usd
CY2023Q4	BFRI	Assets Held For Sale Not Part Of Disposal Group Accumulated Amortization Current AssetsHeldForSaleNotPartOfDisposalGroupAccumulatedAmortizationCurrent		usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent		usd
CY2023Q4	BFRI	Accrued Research And Development AccruedResearchAndDevelopment		usd
CY2024Q3	BFRI	Accrued Legal Settlement Expenses Current AccruedLegalSettlementExpensesCurrent		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2024Q3	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense		usd
	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense		usd
CY2024Q3	BFRI	Lessee Operating Lease Liability Payments Due After Year Three LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40943
	dei	Entity Registrant Name EntityRegistrantName	Biofrontera Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3765675
	dei	Entity Address Address Line1 EntityAddressAddressLine1	120 Presidential Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 330
	dei	Entity Address City Or Town EntityAddressCityOrTown	Woburn
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01801
	dei	City Area Code CityAreaCode	(781)
	dei	Local Phone Number LocalPhoneNumber	245-1325
	dei	Entity Information Former Legal Or Registered Name EntityInformationFormerLegalOrRegisteredName	Not Applicable
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7749211	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2873000	usd
CY2024Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	4874000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	6526000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	10908000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	350000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	425000	usd
CY2024Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	2300000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	16931000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1081000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1612000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	39000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2629000	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	383000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	670000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	691000	usd
CY2024Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	4655000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	4487000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	3904000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11032000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18088000	usd
CY2024Q3	BFRI	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	1601000	usd
CY2023Q4	BFRI	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	4210000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	324000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	804000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	29000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	37000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	12986000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	23139000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	35000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	35000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6529792	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6529792	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1517628	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1517628	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	121536000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	104441000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116013000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-99650000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5530000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4793000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18516000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27932000	usd
CY2024Q3	BFRI	Products Revenues Net ProductsRevenuesNet	9012000	usd
CY2023Q3	BFRI	Products Revenues Net ProductsRevenuesNet	8879000	usd
	BFRI	Products Revenues Net ProductsRevenuesNet	24744000	usd
	BFRI	Products Revenues Net ProductsRevenuesNet	23423000	usd
CY2023Q3	BFRI	Revenues Related Party RevenuesRelatedParty	17000	usd
	BFRI	Revenues Related Party RevenuesRelatedParty	18000	usd
	BFRI	Revenues Related Party RevenuesRelatedParty	52000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9012000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8896000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24762000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23475000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	669000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1306000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	200000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	100000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	13972000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	13516000	usd
	us-gaap	Operating Expenses OperatingExpenses	42287000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4960000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4620000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15498000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18812000	usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	680000	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-598000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1329000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2001000	usd
CY2024Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2000	usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2212000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-12000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-6635000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-316000	usd
CY2024Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	8000	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-142000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1995000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-256000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	35000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	154000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	65000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-706000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1721000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-840000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4825000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6341000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16338000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23637000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5669000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-6342000	usd
	BFRI	Products Revenues Net ProductsRevenuesNet	24744000	usd
CY2023Q3	BFRI	Revenues Related Party RevenuesRelatedParty	17000	usd
	BFRI	Revenues Related Party RevenuesRelatedParty	52000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9012000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8896000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24762000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23475000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	669000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1306000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	200000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	100000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	13972000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	13516000	usd
	us-gaap	Operating Expenses OperatingExpenses	40260000	usd
	us-gaap	Operating Expenses OperatingExpenses	42287000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4960000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4620000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15498000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18812000	usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	680000	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-598000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-12000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1995000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-256000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-32000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	154000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	65000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-706000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-840000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4825000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5666000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6341000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16338000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5669000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-6342000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16363000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23657000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.98
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-17.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-17.57
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1346264	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1346264	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	10911000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	288000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5669000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5530000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16363000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23657000	usd
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.98
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.64
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.64
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-17.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-17.57
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5773993	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4833091	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1346264	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1346264	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	10911000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	288000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5669000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5530000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4793000	usd
	BFRI	Conversion Of Series B1 Preferred Into Series B2 Preferred Value ConversionOfSeriesB1PreferredIntoSeriesB2PreferredValue	3570000	usd
	BFRI	Stock Issuance Of Series B Preferred Stock And Warrants Value StockIssuanceOfSeriesBPreferredStockAndWarrantsValue	12810000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	720000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16363000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5530000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	7173000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	207000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-6342000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1038000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	23878000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	23878000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	817000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23657000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1038000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1038000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16363000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23657000	usd
	us-gaap	Depreciation Depreciation	62000	usd
	us-gaap	Depreciation Depreciation	65000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	541000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	390000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	325000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	314000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6635000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	100000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1329000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2001000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	720000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	817000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	111000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	158000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-316000	usd
	BFRI	Noncash Interest Expense NoncashInterestExpense	248000	usd
	BFRI	Noncash Interest Expense NoncashInterestExpense	296000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4793000	usd
	BFRI	Conversion Of Series B1 Preferred Into Series B2 Preferred Value ConversionOfSeriesB1PreferredIntoSeriesB2PreferredValue	3570000	usd
	BFRI	Stock Issuance Of Series B Preferred Stock And Warrants Value StockIssuanceOfSeriesBPreferredStockAndWarrantsValue	12810000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	720000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16363000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5530000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	7173000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	207000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	23878000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	817000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23657000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1038000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16363000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23657000	usd
	us-gaap	Depreciation Depreciation	62000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	541000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	390000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	325000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6635000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	100000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1329000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	720000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	817000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	111000	usd
	BFRI	Noncash Interest Expense NoncashInterestExpense	248000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-177000	usd
	us-gaap	Increase Decrease In Due From Other Related Parties Current IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent	-19000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-347000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-5159000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4380000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8900000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-3318000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-511000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-375000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	164000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	197000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9253000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16029000	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	57000	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	560000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	50000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	546000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	7662000	usd
	BFRI	Proceeds From Exercise Of Warrants ProceedsFromExerciseOfWarrants	7438000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	357000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1697000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1543000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17408000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3073000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-177000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	204000	usd
	us-gaap	Increase Decrease In Due From Other Related Parties Current IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent	-19000	usd
	us-gaap	Increase Decrease In Due From Other Related Parties Current IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent	-3652000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-34000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-347000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4380000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8900000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-3318000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	6137000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-511000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-375000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	164000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	197000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9253000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16029000	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	57000	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	560000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	50000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	546000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	7662000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	13546000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	357000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	11849000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	3958000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10785000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1697000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1530000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13786000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1543000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17408000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3073000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3622000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1722000	usd
	us-gaap	Interest Paid Net InterestPaidNet	31000	usd
	BFRI	Interest Paid Related Party InterestPaidRelatedParty	22000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	25000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	21000	usd
	BFRI	Conversion Of Warrant Liability To Equity ConversionOfWarrantLiabilityToEquity	5372000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	27000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	147000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9300000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16000000.0	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116000000.0	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2900000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1300000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3622000	usd
	us-gaap	Interest Paid Net InterestPaidNet	31000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	25000	usd
	BFRI	Conversion Of Warrant Liability To Equity ConversionOfWarrantLiabilityToEquity	5372000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	27000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	147000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9300000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16000000.0	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116000000.0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zaa5N6VT5Lw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zlheDCrcJnG">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions by management that affect the reported amounts of assets and liabilities, as well as disclosure of contingent assets and liabilities, as reported on the balance sheet date, and the reported amounts of revenues and expenses arising during the reporting period. The main areas in which assumptions, estimates and the exercising of judgment are appropriate relate to, valuation allowances for receivables and inventory, and warrant liabilities, realization of intangible and other long-lived assets, product sales allowances and reserves, share-based payments, accrual of research and development expenses and income taxes including deferred tax assets and liabilities. Estimates are based on historical experience and other assumptions that are considered appropriate in the circumstances. They are continuously reviewed but may vary from the actual values.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zaa5N6VT5Lw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zlheDCrcJnG">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions by management that affect the reported amounts of assets and liabilities, as well as disclosure of contingent assets and liabilities, as reported on the balance sheet date, and the reported amounts of revenues and expenses arising during the reporting period. The main areas in which assumptions, estimates and the exercising of judgment are appropriate relate to, valuation allowances for receivables and inventory, and warrant liabilities, realization of intangible and other long-lived assets, product sales allowances and reserves, share-based payments, accrual of research and development expenses and income taxes including deferred tax assets and liabilities. Estimates are based on historical experience and other assumptions that are considered appropriate in the circumstances. They are continuously reviewed but may vary from the actual values.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	BFRI	Fair Value Warrant Liability Purchase Warrant FairValueWarrantLiabilityPurchaseWarrant	1601000	usd
CY2023Q4	BFRI	Fair Value Warrant Liability Purchase Warrant FairValueWarrantLiabilityPurchaseWarrant	4210000	usd
	BFRI	Stock Issued During Period Shares Investment In Equity Securities StockIssuedDuringPeriodSharesInvestmentInEquitySecurities	3019	shares
CY2023	BFRI	Stock Issued During Period Shares Investment In Equity Securities StockIssuedDuringPeriodSharesInvestmentInEquitySecurities	177465	shares
CY2022Q4	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	82000	usd
CY2024Q3	BFRI	Fair Value Warrant Liability Purchase Warrant FairValueWarrantLiabilityPurchaseWarrant	1601000	usd
CY2023Q4	BFRI	Fair Value Warrant Liability Purchase Warrant FairValueWarrantLiabilityPurchaseWarrant	4210000	usd
	BFRI	Stock Issued During Period Shares Investment In Equity Securities StockIssuedDuringPeriodSharesInvestmentInEquitySecurities	3019	shares
CY2023	BFRI	Stock Issued During Period Shares Investment In Equity Securities StockIssuedDuringPeriodSharesInvestmentInEquitySecurities	177465	shares
CY2022Q4	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	82000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Provision Related To Current Period RevenueFromContractWithCustomerAllowancesAndReservesProvisionRelatedToCurrentPeriod	429000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Credit Payments Made During Period RevenueFromContractWithCustomerAllowancesAndReservesCreditPaymentsMadeDuringPeriod	378000	usd
CY2023Q3	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	133000	usd
CY2023Q4	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	112000	usd
CY2023Q4	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	112000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Provision Related To Current Period RevenueFromContractWithCustomerAllowancesAndReservesProvisionRelatedToCurrentPeriod	189000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Credit Payments Made During Period RevenueFromContractWithCustomerAllowancesAndReservesCreditPaymentsMadeDuringPeriod	179000	usd
CY2024Q3	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	122000	usd
CY2024Q3	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	122000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Provision Related To Current Period RevenueFromContractWithCustomerAllowancesAndReservesProvisionRelatedToCurrentPeriod	429000	usd
CY2023Q4	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	112000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Provision Related To Current Period RevenueFromContractWithCustomerAllowancesAndReservesProvisionRelatedToCurrentPeriod	189000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Credit Payments Made During Period RevenueFromContractWithCustomerAllowancesAndReservesCreditPaymentsMadeDuringPeriod	179000	usd
CY2024Q3	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	122000	usd
CY2024Q3	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	122000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	300000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	200000	usd
CY2024Q3	BFRI	Assets Held For Sale Not Part Of Disposal Group Gross Current AssetsHeldForSaleNotPartOfDisposalGroupGrossCurrent	4600000	usd
CY2024Q3	BFRI	Assets Held For Sale Not Part Of Disposal Group Accumulated Amortization Current AssetsHeldForSaleNotPartOfDisposalGroupAccumulatedAmortizationCurrent	2300000	usd
CY2024Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	2300000	usd
CY2024Q3	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	4600000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P11Y
CY2024Q3	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	100000	usd
	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	300000	usd
	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	300000	usd
CY2024Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	2300000	usd
CY2024Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2500000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	300000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	200000	usd
CY2024Q3	BFRI	Assets Held For Sale Not Part Of Disposal Group Gross Current AssetsHeldForSaleNotPartOfDisposalGroupGrossCurrent	4600000	usd
CY2024Q3	BFRI	Assets Held For Sale Not Part Of Disposal Group Accumulated Amortization Current AssetsHeldForSaleNotPartOfDisposalGroupAccumulatedAmortizationCurrent	2300000	usd
CY2024Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	2300000	usd
CY2024Q3	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	4600000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P11Y
CY2024Q3	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	100000	usd
CY2023Q3	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	100000	usd
	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	300000	usd
	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	300000	usd
CY2024Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	2300000	usd
CY2024Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2500000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2873000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1343000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2873000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1343000	usd
CY2024Q3	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	200000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	200000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3073000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2185000	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	679000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1064000	usd
CY2024Q3	BFRI	Accrued Research And Development AccruedResearchAndDevelopment	581000	usd
CY2024Q3	BFRI	Accrued Product Revenue Reserves AccruedProductRevenueReserves	122000	usd
CY2023Q4	BFRI	Accrued Product Revenue Reserves AccruedProductRevenueReserves	149000	usd
CY2024Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	40000	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	118000	usd
CY2023Q4	BFRI	Accrued Legal Settlement Expenses Current AccruedLegalSettlementExpensesCurrent	403000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	662000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	568000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4655000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4487000	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	35000000	shares
CY2024Q3	us-gaap	Share Price SharePrice	1.06
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.000	pure
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0420	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	99486	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	39.26
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1242722	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.38
CY2024Q3	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	200000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	200000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3073000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1543000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2571000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2185000	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	679000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1064000	usd
CY2024Q3	BFRI	Accrued Research And Development AccruedResearchAndDevelopment	581000	usd
CY2024Q3	BFRI	Accrued Product Revenue Reserves AccruedProductRevenueReserves	122000	usd
CY2023Q4	BFRI	Accrued Product Revenue Reserves AccruedProductRevenueReserves	149000	usd
CY2024Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	40000	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	118000	usd
CY2023Q4	BFRI	Accrued Legal Settlement Expenses Current AccruedLegalSettlementExpensesCurrent	403000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	662000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4487000	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	35000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6529792	shares
CY2024Q3	us-gaap	Share Price SharePrice	1.06
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.000	pure
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0420	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	99486	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	39.26
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1242722	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.38
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	16764	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	14.19
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1325444	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.04
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y7M24D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	59324	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	40.76
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y10M13D
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1300000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M17D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	16764	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	14.19
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1325444	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.04
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y7M24D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	59324	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	40.76
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y10M13D
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1300000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M17D
CY2023Q3	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense	90000	usd
	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense	268000	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	17000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	13000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	56000	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-142000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1995000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-256000	usd
CY2023Q3	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense	90000	usd
	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense	268000	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	17000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	13000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	56000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	111000	usd
CY2024Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	8000	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-142000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1995000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-256000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5669000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-6342000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16363000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23657000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5773993	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5773993	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1366842	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1366842	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4833091	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4833091	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1346264	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1346264	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.98
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.98
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.64
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.64
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.39
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5669000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-6342000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16363000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23657000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5773993	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5773993	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1366842	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1366842	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4833091	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4833091	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1346264	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.98
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.64
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.64
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-17.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-17.57
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20728822	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	563387	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20728822	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	563387	shares
	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	option to extend the term of the lease for a five-year period
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-17.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-17.57
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	563387	shares
	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	option to extend the term of the lease for a five-year period
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	193000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	590000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	246000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	37000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1066000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	72000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	994000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	670000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	324000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	994000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	193000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	590000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	246000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	37000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1066000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	72000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	994000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	670000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	324000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	994000	usd

Files In Submission

Name	View Source	Status
0001493152-24-045220-index-headers.html	Edgar Link	pending
0001493152-24-045220-index.html	Edgar Link	pending
0001493152-24-045220.txt	Edgar Link	pending
0001493152-24-045220-xbrl.zip	Edgar Link	pending
bfri-20240930.xsd	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
bfri-20240930_cal.xml	Edgar Link	unprocessable
bfri-20240930_def.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
bfri-20240930_lab.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
0001493152-24-045220-index-headers.html	Edgar Link	pending
0001493152-24-045220-index.html	Edgar Link	pending
0001493152-24-045220.txt	Edgar Link	pending
0001493152-24-045220-xbrl.zip	Edgar Link	pending
bfri-20240930.xsd	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
bfri-20240930_def.xml	Edgar Link	unprocessable
bfri-20240930_lab.xml	Edgar Link	unprocessable
bfri-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bfri-20240930_cal.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bfri-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BFRI
Biofrontera Inc. Stock $bfri

2024 Q4 Form 10-Q Financial Statement

#000149315224045220 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BFRI Biofrontera Inc. Stock $bfri

2024 Q4 Form 10-Q Financial Statement

#000149315224045220 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BFRI
Biofrontera Inc. Stock $bfri